Australia's recent move to lower the starting age for bowel (colorectal) cancer screening from 50 down to 45 years old will mean better outcomes -- but it will also increase the burden on an already ...

The threshold at which traces of blood in a fecal immunochemical test (FIT) trigger further investigation for possible bowel cancer will be lowered from February. The level will be reduced from 120 to ...

Lindsay Curtis is a health & medical writer in South Florida. She worked as a communications professional for health nonprofits and the University of Toronto’s Faculty of Medicine and Faculty of ...

Trying to juggle work, a packed social calendar, stretched budgets, and family time during the holiday season from late November into the new year can be stressful for anyone. But if you’re also ...

Please provide your email address to receive an email when new articles are posted on . Use of teduglutide for short bowel syndrome did not increase incidence of GI malignancies. The results support ...

BERLIN — Pairing a screening or surveillance colonoscopy with a same-day esophagogastroduodenoscopy (EGD) proved feasible and yielded clinically relevant upper gastrointestinal (GI) findings, ...

A new study shows that if you adopt a healthier lifestyle after bowel screening, it can lower your risk of both bowel cancer and other chronic diseases. Previous studies have estimated that ...

− Treatment with Vutrisiran Led to 37- 49% Lower Rates of Gastrointestinal Events, a Multisystem Manifestation of ATTR-CM, Across Multiple Treatment Groups, Compared to Placebo – − Additional Analyses ...

Lower won for her dual role in Season 2 of the surreal workplace drama. A handwritten joke on the back of her acceptance speech notes read, “Let me out.” By Alexis Soloski Let’s hope that Helena and ...

Gastrointestinal cancers include any cancer of the GI tract—stomach, liver, esophageal, pancreatic and colorectal. They represent more than 25% of all cancers, with 5 million new cases of ...

A prospective trial of gastrointestinal cancer patients showed the feasibility of preemptive genetic testing for DPYD/UGT1A1 variants associated with increased chemotherapy toxicity. Genotype-guided ...